PlainPharmaWatch

CMS Open Payments · Program Year 2024

Biobeat USA Inc.

Biobeat USA Inc. reported $11,552.38 across General Payments, Research, and Ownership to 85 physicians and teaching hospitals across 85 transactions.

See the rankings → How this is sourced
$11.6K Below-median payer
All-tracks total
85 Below-median volume
Transactions
85 Below-median reach
Recipients
#1623
of 1,925 companies

Biobeat USA Inc. reported $11,552.38 across all CMS Open Payments tracks (General + Research + Ownership) to 85 physicians and teaching hospitals in Program Year 2024 - ranking #1623 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $11,552.38, averaging $135.91 per recipient.

Biobeat USA Inc.'s payment reach score

Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.

Overall reach score

F

14/100

Total payments

F

10/100

Transaction volume

F

11/100

Physician reach

F

11/100

Payment type diversity

F

23/100

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer biobeat-usa-inc Biobeat USA Inc.

$11.6K · #1623/1,925 · 0.0% industry · PY2024

  • TOT $11.6K
  • RANK #1623
  • SHARE 0.0%
  • TXN 85
  • RCP 85
  • CAT 2
  • GEN $11.6K
  • TOP1 69.2%
  • PY 2024

Volume peers

Nearest volume peer: Biolase MG LLC ($11.5K)

EnableCV Inc.$11.6KGreiner Bio-One North Americ…$11.6KBiobeat USA Inc. (this)$11.6KBiolase MG LLC$11.5KXenco Medical LLC$11.5K
All-tracks payment totals near Biobeat USA Inc. (CMS Open Payments PY2024)

Biobeat USA Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for Biobeat USA Inc.

The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Biobeat USA Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.

Of the 2 general-payment categories charted below, "Consulting Fee" is the largest at $8.9K across 3 transactions, 76.8% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 2 types of general payments, Biobeat USA Inc.'s largest category was "Consulting Fee" at $8.9K - 76.8% of General Payments.

How Biobeat USA Inc. divides its payments

Ranked by total dollars reported per category

1. Consulting Fee$8.9K2. Food and Beverage$2.7K
Payment Type Amount Transactions
Consulting Fee $8.9K 3
Food and Beverage $2.7K 82

Recipient Concentration in General Payments

The five largest recipient relationships account for $9,138.30 (79.1%) of $11,552.38 in this company's General Payments records across 81 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Biobeat USA Inc.

The five named recipients with the highest reported General Payments from this company

Amir Lerman$8.0KOren J MECHANIC$875.00Kunal Manmohan Patel$100.00Megan Hammer$81.65Dustin Bartlett$81.65
  1. 1

    Amir Lerman

    $8,000.00 across 2 reported transactions

  2. 2

    Oren J MECHANIC

    $875.00 across 1 reported transactions

  3. 3

    Kunal Manmohan Patel

    $100.00 across 1 reported transactions

  4. 4

    Megan Hammer

    $81.65 across 1 reported transactions

  5. 5

    Dustin Bartlett

    $81.65 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Spend vs. Concentration

Biobeat USA Inc. ranks #1623 of 1,925 by total payments (bottom 16% by spend) but is notably more concentrated than that alone would suggest -- #384 of 1,838 by HHI (top 21% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.

00.30.50.81.14770.94804.24837.54870.84904.1Total payments ($M)Concentration (HHI, 0-10,000)
Biobeat USA Inc. (highlighted) among its 12 nearest HHI-concentration neighbors, Program Year 2024. Dashed lines mark this neighborhood's median payment total and median HHI. Hover a point for the company name. Source: company_concentration (CMS Open Payments general-payment recipients).
View all 12 companies in this HHI neighborhood as a list

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Biobeat USA Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Biobeat USA Inc..

ETS Wound Care LLC

HHI 4864

Terumo BCT, Inc.

HHI 4865

Remington Medical, Inc.

HHI 4851

D.T. Davis Enterprises, Ltd

HHI 4874

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Biobeat USA Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Put this to use

Biobeat USA Inc. ranks #1623 of 1,925 by all-tracks total payments, led by "Consulting Fee".

Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Biobeat USA Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.